Cargando…

Therapeutic Effect of TSG-6 Engineered iPSC-Derived MSCs on Experimental Periodontitis in Rats: A Pilot Study

BACKGROUND: We derived mesenchymal stem cells (MSCs) from rat induced pluripotent stem cells (iPSCs) and transduced them with tumor necrosis factor alpha-stimulated gene-6 (TSG-6), to test whether TSG-6 overexpression would boost the therapeutic effects of iPSC-derived MSCs in experimental periodont...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Heng, Aprecio, Raydolfo M., Zhou, Xiaodong, Wang, Qi, Zhang, Wu, Ding, Yi, Li, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076279/
https://www.ncbi.nlm.nih.gov/pubmed/24979372
http://dx.doi.org/10.1371/journal.pone.0100285
_version_ 1782323468846497792
author Yang, Heng
Aprecio, Raydolfo M.
Zhou, Xiaodong
Wang, Qi
Zhang, Wu
Ding, Yi
Li, Yiming
author_facet Yang, Heng
Aprecio, Raydolfo M.
Zhou, Xiaodong
Wang, Qi
Zhang, Wu
Ding, Yi
Li, Yiming
author_sort Yang, Heng
collection PubMed
description BACKGROUND: We derived mesenchymal stem cells (MSCs) from rat induced pluripotent stem cells (iPSCs) and transduced them with tumor necrosis factor alpha-stimulated gene-6 (TSG-6), to test whether TSG-6 overexpression would boost the therapeutic effects of iPSC-derived MSCs in experimental periodontitis. METHODS: A total of 30 female Sprague-Dawley (SD) rats were randomly divided into four groups: healthy control group (Group-N, n = 5), untreated periodontitis group (Group-P, n = 5), iPS-MSCs-treated and iPSC-MSCs/TSG-6-treated periodontitis groups (Group-P1 and P2, n = 10 per group). Experimental periodontitis was established by ligature and infection with Porphyromonas gingivalis around the maxillae first molar bilaterally. MSC-like cells were generated from rat iPSCs, and transducted with TSG-6. iPSC-MSCs or iPSC-MSCs/TSG-6 were administrated to rats in Group-P1 or P2 intravenously and topically, once a week for three weeks. Blood samples were obtained one week post-injection for the analysis of serum pro-inflammatory cytokines. All animals were killed 3 months post-treatment; maxillae were then dissected for histological analysis, tartrate-resistant acid phosphatase (TRAP) staining, and morphological analysis of alveolar bone loss. RESULTS: Administration of iPSC-MSC/TSG-6 significantly decreased serum levels of IL-1β and TNF-α in the Group-P2 rats (65.78 pg/ml and 0.56 pg/ml) compared with those in Group-P (168.31 pg/ml and 1.15 pg/ml respectively) (p<0.05). Both alveolar bone loss and the number of TRAP-positive osteoclasts showed a significant decrease in rats that received iPSC-MSC/TSG-6 treatment compared to untreated rats in Group-P (p<0.05), CONCLUSIONS: We demonstrated that overexpression of TSG-6 in rat iPSC-derived MSCs were capable of decreasing inflammation in experimental periodontitis and inhibiting alveolar bone resorption. This may potentially serve as an alternative stem-cell-based approach in the treatment and regeneration of periodontal tissues.
format Online
Article
Text
id pubmed-4076279
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40762792014-07-02 Therapeutic Effect of TSG-6 Engineered iPSC-Derived MSCs on Experimental Periodontitis in Rats: A Pilot Study Yang, Heng Aprecio, Raydolfo M. Zhou, Xiaodong Wang, Qi Zhang, Wu Ding, Yi Li, Yiming PLoS One Research Article BACKGROUND: We derived mesenchymal stem cells (MSCs) from rat induced pluripotent stem cells (iPSCs) and transduced them with tumor necrosis factor alpha-stimulated gene-6 (TSG-6), to test whether TSG-6 overexpression would boost the therapeutic effects of iPSC-derived MSCs in experimental periodontitis. METHODS: A total of 30 female Sprague-Dawley (SD) rats were randomly divided into four groups: healthy control group (Group-N, n = 5), untreated periodontitis group (Group-P, n = 5), iPS-MSCs-treated and iPSC-MSCs/TSG-6-treated periodontitis groups (Group-P1 and P2, n = 10 per group). Experimental periodontitis was established by ligature and infection with Porphyromonas gingivalis around the maxillae first molar bilaterally. MSC-like cells were generated from rat iPSCs, and transducted with TSG-6. iPSC-MSCs or iPSC-MSCs/TSG-6 were administrated to rats in Group-P1 or P2 intravenously and topically, once a week for three weeks. Blood samples were obtained one week post-injection for the analysis of serum pro-inflammatory cytokines. All animals were killed 3 months post-treatment; maxillae were then dissected for histological analysis, tartrate-resistant acid phosphatase (TRAP) staining, and morphological analysis of alveolar bone loss. RESULTS: Administration of iPSC-MSC/TSG-6 significantly decreased serum levels of IL-1β and TNF-α in the Group-P2 rats (65.78 pg/ml and 0.56 pg/ml) compared with those in Group-P (168.31 pg/ml and 1.15 pg/ml respectively) (p<0.05). Both alveolar bone loss and the number of TRAP-positive osteoclasts showed a significant decrease in rats that received iPSC-MSC/TSG-6 treatment compared to untreated rats in Group-P (p<0.05), CONCLUSIONS: We demonstrated that overexpression of TSG-6 in rat iPSC-derived MSCs were capable of decreasing inflammation in experimental periodontitis and inhibiting alveolar bone resorption. This may potentially serve as an alternative stem-cell-based approach in the treatment and regeneration of periodontal tissues. Public Library of Science 2014-06-30 /pmc/articles/PMC4076279/ /pubmed/24979372 http://dx.doi.org/10.1371/journal.pone.0100285 Text en © 2014 Yang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Yang, Heng
Aprecio, Raydolfo M.
Zhou, Xiaodong
Wang, Qi
Zhang, Wu
Ding, Yi
Li, Yiming
Therapeutic Effect of TSG-6 Engineered iPSC-Derived MSCs on Experimental Periodontitis in Rats: A Pilot Study
title Therapeutic Effect of TSG-6 Engineered iPSC-Derived MSCs on Experimental Periodontitis in Rats: A Pilot Study
title_full Therapeutic Effect of TSG-6 Engineered iPSC-Derived MSCs on Experimental Periodontitis in Rats: A Pilot Study
title_fullStr Therapeutic Effect of TSG-6 Engineered iPSC-Derived MSCs on Experimental Periodontitis in Rats: A Pilot Study
title_full_unstemmed Therapeutic Effect of TSG-6 Engineered iPSC-Derived MSCs on Experimental Periodontitis in Rats: A Pilot Study
title_short Therapeutic Effect of TSG-6 Engineered iPSC-Derived MSCs on Experimental Periodontitis in Rats: A Pilot Study
title_sort therapeutic effect of tsg-6 engineered ipsc-derived mscs on experimental periodontitis in rats: a pilot study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076279/
https://www.ncbi.nlm.nih.gov/pubmed/24979372
http://dx.doi.org/10.1371/journal.pone.0100285
work_keys_str_mv AT yangheng therapeuticeffectoftsg6engineeredipscderivedmscsonexperimentalperiodontitisinratsapilotstudy
AT aprecioraydolfom therapeuticeffectoftsg6engineeredipscderivedmscsonexperimentalperiodontitisinratsapilotstudy
AT zhouxiaodong therapeuticeffectoftsg6engineeredipscderivedmscsonexperimentalperiodontitisinratsapilotstudy
AT wangqi therapeuticeffectoftsg6engineeredipscderivedmscsonexperimentalperiodontitisinratsapilotstudy
AT zhangwu therapeuticeffectoftsg6engineeredipscderivedmscsonexperimentalperiodontitisinratsapilotstudy
AT dingyi therapeuticeffectoftsg6engineeredipscderivedmscsonexperimentalperiodontitisinratsapilotstudy
AT liyiming therapeuticeffectoftsg6engineeredipscderivedmscsonexperimentalperiodontitisinratsapilotstudy